WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 3.07 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.93M shares, a 9.88% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 145.00K shares, a 78.92% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 657.50K shares, a 974.49% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 35.00K shares.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.04M shares, a 165.49% increase from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.52M shares, a 33.28% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.28M shares, a 44.18% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.58M shares, a 26.79% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.93M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 3.07M shares 10-Q · filed 2026-08-06 | 3.73M shares derived: sum of 3 quarters · filed 2026-08-06 | 3.76M shares derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 145.00K shares 10-Q · filed 2026-05-07 | 802.50K shares derived: sum of 2 quarters · filed 2026-05-07 | 837.50K shares derived: sum of 3 quarters · filed 2026-05-07 | 3.50M shares derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2025-12-31 | 657.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 692.50K shares derived: sum of 2 quarters · filed 2026-03-12 | 3.36M shares derived: sum of 3 quarters · filed 2026-03-12 | 4.04M shares 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 2.70M shares derived: sum of 2 quarters · filed 2025-11-06 | 3.39M shares 10-Q · filed 2025-11-06 | 3.45M shares derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2025-06-30 | 2.66M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 3.35M shares 10-Q · filed 2025-08-07 | 3.41M shares derived: sum of 3 quarters · filed 2025-08-07 | 3.41M shares derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2025-03-31 | 687.98K shares 10-Q · filed 2025-05-08 | 749.17K shares derived: sum of 2 quarters · filed 2025-05-08 | 749.17K shares derived: sum of 3 quarters · filed 2025-05-08 | 1.12M shares derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2024-12-31 | 61.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 61.19K shares derived: sum of 2 quarters · filed 2025-03-28 | 434.85K shares derived: sum of 3 quarters · filed 2025-03-28 | 1.52M shares 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-06 | 373.66K shares derived: sum of 2 quarters · filed 2024-11-06 | 1.46M shares 10-Q · filed 2024-11-06 | 1.97M shares derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2024-06-30 | 373.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 1.46M shares 10-Q · filed 2024-08-07 | 1.97M shares derived: sum of 3 quarters · filed 2024-08-07 | 2.06M shares derived: sum of 4 quarters · filed 2024-08-07 | |||
| 2024-03-31 | 1.09M shares 10-Q · filed 2024-05-08 | 1.59M shares derived: sum of 2 quarters · filed 2024-05-08 | 1.69M shares derived: sum of 3 quarters · filed 2024-05-08 | 2.11M shares derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2023-12-31 | 506.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 601.70K shares derived: sum of 2 quarters · filed 2024-03-13 | 1.02M shares derived: sum of 3 quarters · filed 2024-03-13 | 2.28M shares 10-K · filed 2024-03-13 | |||
| 2023-09-30 | 95.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 514.20K shares derived: sum of 2 quarters · filed 2023-11-08 | 1.78M shares 10-Q · filed 2023-11-08 | 1.85M shares derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2023-06-30 | 419.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.68M shares 10-Q · filed 2023-08-09 | 1.76M shares derived: sum of 3 quarters · filed 2023-08-09 | 2.05M shares derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2023-03-31 | 1.26M shares 10-Q · filed 2023-05-10 | 1.34M shares derived: sum of 2 quarters · filed 2023-05-10 | 1.63M shares derived: sum of 3 quarters · filed 2023-05-10 | 2.50M shares derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2022-12-31 | 74.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 373.40K shares derived: sum of 2 quarters · filed 2023-03-29 | 1.24M shares derived: sum of 3 quarters · filed 2023-03-29 | 1.58M shares 10-K · filed 2023-03-29 | |||
| 2022-09-30 | 299.00K shares 10-Q · filed 2022-11-09 | 1.16M shares derived: sum of 2 quarters · filed 2022-11-09 | 1.51M shares 10-Q · filed 2022-11-09 | 2.03M shares derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2022-06-30 | 862.94K shares 10-Q · filed 2022-08-10 | 1.21M shares 10-Q · filed 2022-08-10 | 1.73M shares derived: sum of 3 quarters · filed 2022-08-10 | 2.40M shares derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2022-03-31 | 346.70K shares 10-Q · filed 2022-05-12 | 867.60K shares derived: sum of 2 quarters · filed 2022-05-12 | 1.54M shares derived: sum of 3 quarters · filed 2022-11-09 | 1.60M shares derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-12-31 | 520.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 1.19M shares derived: sum of 2 quarters · filed 2022-11-09 | 1.25M shares derived: sum of 3 quarters · filed 2022-11-09 | 1.25M shares 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 669.73K shares 10-Q · filed 2022-11-09 | 727.62K shares derived: sum of 2 quarters · filed 2022-11-09 | 727.62K shares 10-Q · filed 2022-11-09 | 1.64M shares derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | 57.89K shares 10-Q · filed 2022-08-10 | 57.89K shares 10-Q · filed 2022-08-10 | 287.96K shares 10-Q · filed 2021-08-11 | 967.48K shares derived: sum of 3 quarters · filed 2022-08-10 | 967.48K shares derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-12 | 71.43K shares 10-Q · filed 2021-05-17 | 909.59K shares derived: sum of 2 quarters · filed 2022-05-12 | 909.59K shares derived: sum of 3 quarters · filed 2022-05-12 | 1.17M shares derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | 909.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 909.59K shares derived: sum of 2 quarters · filed 2021-11-10 | 1.17M shares derived: sum of 3 quarters · filed 2021-11-10 | 962.72K shares 10-K · filed 2021-03-11 | |||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-10 | 260.72K shares derived: sum of 2 quarters · filed 2021-11-10 | 53.13K shares 10-Q · filed 2021-11-10 | 962.72K shares 10-Q · filed 2020-11-10 | 1.01M shares derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | 260.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 962.72K shares 10-Q · filed 2020-08-12 | 1.01M shares derived: sum of 3 quarters · filed 2021-03-11 | 1.01M shares derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2020-03-31 | 702.00K shares 10-Q · filed 2020-05-07 | 746.30K shares derived: sum of 2 quarters · filed 2021-03-11 | 746.30K shares derived: sum of 3 quarters · filed 2021-03-11 | 3.55M shares derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-12-31 | 44.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 44.30K shares derived: sum of 2 quarters · filed 2021-03-11 | 2.85M shares derived: sum of 3 quarters · filed 2021-03-11 | 4.67M shares 10-K · filed 2021-03-11 | |||
| 2019-09-30 | 0.00 shares 10-Q · filed 2020-11-10 | 2.80M shares derived: sum of 2 quarters · filed 2020-11-10 | 4.62M shares 10-Q · filed 2019-11-07 | 4.62M shares derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | 2.80M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 4.62M shares 10-Q · filed 2019-08-08 | 4.62M shares derived: sum of 3 quarters · filed 2020-03-16 | 4.72M shares derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2019-03-31 | 1.82M shares 10-Q · filed 2019-05-09 | 1.82M shares derived: sum of 2 quarters · filed 2020-03-16 | 1.92M shares derived: sum of 3 quarters · filed 2020-03-16 | ||||
| 2018-12-31 | 2.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 100.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 1.62M shares 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | 97.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 1.61M shares 10-Q · filed 2018-11-07 | |||||
| 2018-06-30 | 1.52M shares 10-Q · filed 2018-08-14 | ||||||
| 2017-12-31 | 1.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 1.01M shares 10-K · filed 2019-03-07 | |||||
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-13 | ||||||
| 2016-12-31 | 50.23K shares 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |